- Home
- PR
Browsing Category
PR
Silo Pharma extends research pact for Alzheimer’s and Stress Induced Anxiety Therapeutics
Tue, Oct 18, 2022 08:25 ET
Zai Lab to Announce Third Quarter 2022 Financial Results on November 9, 2022
Tue, Oct 18, 2022 08:25 ET
LEXEO Therapeutics Receives Orphan Drug Designation for LX1004 from European Commission
Tue, Oct 18, 2022 08:25 ET
Ikena Oncology Provides Research & Development Update on IK-930 Program Targeting the Hippo Pathway
Tue, Oct 18, 2022 08:25 ET
Weatherford Enters into $370 Million Amended and Restated Credit Facility
Tue, Oct 18, 2022 08:25 ET